Suchergebnisse - "Milla, Carlos"

PubPharm (18)

1

Safety and efficacy of the epithelial sodium channel blocker idrevloride in people with primary ciliary dyskinesia (CLEAN-PCD) : a multinational, phase 2, randomised, double-blind, placebo-controlled crossover trial

enthalten in: The Lancet. Respiratory medicine | 2024

von Ringshausen, F. | Shapiro, A. | Nielsen, K. | +53

2

Testing the effects of combining azithromycin with inhaled tobramycin for P. aeruginosa in cystic fibrosis : a randomised, controlled clinical trial

enthalten in: Thorax | 2022

von Nichols, D. | Singh, P. | Baines, A. | +61

3

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment

enthalten in: American journal of respiratory and critical care medicine | 2021

von Goss, C. | Heltshe, S. | West, N. | +109

CommentIn: Am J Respir Crit Care Med. 2021 Dec 1;204(11):1245-1247. - PMID 34543576

4

Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP) : a multicentre, randomised, double-blind, placebo-controlled trial

enthalten in: The Lancet. Respiratory medicine | 2019

von Ratjen, F. | Davis, S. | Stanojevic, S. | +93

CommentIn: Lancet Respir Med. 2019 Sep;7(9):730-732. - PMID 31178424

5

KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2018

von Jain, R. | Beckett, V. | Konstan, M. | +7

6

Home Monitoring of Patients with Cystic Fibrosis to Identify and Treat Acute Pulmonary Exacerbations. eICE Study Results

enthalten in: American journal of respiratory and critical care medicine | 2017

von Lechtzin, N. | Mayer-Hamblett, N. | West, N. | +38

CommentIn: Am J Respir Crit Care Med. 2017 Nov 1;196 (9):1090-1092. - PMID 28696781

7

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2017

von Ratjen, F. | Hug, C. | Marigowda, G. | +62

CommentIn: Lancet Respir Med. 2017 Jul;5(7):536-537. - PMID 28606619

8

Use of ibuprofen to assess inflammatory biomarkers in induced sputum : Implications for clinical trials in cystic fibrosis

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2015

von Chmiel, J. | Konstan, M. | Accurso, F. | +30

9

Anti-PcrV antibody in cystic fibrosis : a novel approach targeting Pseudomonas aeruginosa airway infection

enthalten in: Pediatric pulmonology | 2014

von Milla, C. | Chmiel, J. | Accurso, F. | +16

10

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry : a randomised controlled trial

enthalten in: The Lancet. Respiratory medicine | 2013

von Davies, J. | Sheridan, H. | Bell, N. | +8

CommentIn: Lancet Respir Med. 2013 Oct;1(8):591-2. - PMID 24461654